CYP3A5 GENOTYPE IS NOT RELATED TO THE INTRA-PATIENT VARIABILITY OF TACROLIMUS CLEARANCE IN RENAL TRANSPLANT RECIPIENTS

被引：0
|
作者：
Spierings, Natalia M. K. [1 ]
Pashaee, Nilufar [2 ]
Bouamar, Rachida [2 ]
Hesselink, Dennis A. [3 ]
Roodnat, Joke I. [3 ]
van Schaik, Ron H. N.
Weimar, Willem [3 ]
Holt, David W. [1 ]
MacPhee, Iain A. M. [1 ]
van Gelder, Teun [2 ,3 ]
机构：
[1] Univ London, Div Clin Sci, London, England
[2] Erasmus MC, Clin Pharmacol Unit, Rotterdam, Netherlands
[3] Erasmus MC, Div Nephrol & Renal Transplantat, Rotterdam, Netherlands
来源：
TRANSPLANT INTERNATIONAL | 2011年 / 24卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
引用
收藏
页码：80 / 81
页数：2
相关论文
共 50 条
  • [11] Influence of CYP3A5 Polymorphisms on Tacrolimus Dosing in Renal Transplant Recipients
    Kotha, Chandini
    Sahay, Manisha
    TRANSPLANTATION, 2022, 106 (09) : S135 - S135
  • [12] CYP3A5 polymorphisms in renal transplant recipients: influence on tacrolimus treatment
    Chen, Lucy
    Prasad, G. V. Ramesh
    PHARMACOGENOMICS & PERSONALIZED MEDICINE, 2018, 11 : 23 - 33
  • [13] Intra-patient variability in tacrolimus trough concentrations and renal function decline in pediatric renal transplant recipients
    Prytula, Agnieszka A.
    Bouts, Antonia H.
    Mathot, Ron A. A.
    van Gelder, Teun
    Croes, Ludwig K.
    Hop, Wim
    Cransberg, Karlien
    PEDIATRIC TRANSPLANTATION, 2012, 16 (06) : 613 - 618
  • [14] Impact of CYP3A5 genotype on tacrolimus management in adult heart transplant recipients
    Pasternak, Amy
    Hong, Je-Won
    Lewis, Sarah
    PHARMACOGENETICS AND GENOMICS, 2025, 35 (01): : 35 - 36
  • [15] AN EFFECT OF DONOR-RECIPIENT CYP3A5 GENOTYPE COMBINATION ON TACROLIMUS EXPOSURE IN RENAL TRANSPLANT RECIPIENTS
    Warzyszynska, Karola
    Karpeta, Edyta
    Kosieradzki, Maciej
    TRANSPLANT INTERNATIONAL, 2021, 34 : 257 - 257
  • [16] The Effect of Weight and CYP3A5 Genotype on the Population Pharmacokinetics of Tacrolimus in Stable Paediatric Renal Transplant Recipients
    Prytula, Agnieszka A.
    Cransberg, Karlien
    Bouts, Antonia H. M.
    van Schaik, Ron H. N.
    de Jong, Huib
    de Wildt, Saskia N.
    Mathot, Ron A. A.
    CLINICAL PHARMACOKINETICS, 2016, 55 (09) : 1129 - 1143
  • [17] CYP3A5 and ABCB1 genotype influence tacrolimus and sirolimus pharmacokinetics in renal transplant recipients
    Li, Yi
    Yan, Lin
    Shi, Yunying
    Bai, Yangjuan
    Tang, Jiangtao
    Wang, Lanlan
    SPRINGERPLUS, 2015, 4
  • [18] The Effect of Weight and CYP3A5 Genotype on the Population Pharmacokinetics of Tacrolimus in Stable Paediatric Renal Transplant Recipients
    Agnieszka A. Prytuła
    Karlien Cransberg
    Antonia H. M. Bouts
    Ron H. N. van Schaik
    Huib de Jong
    Saskia N. de Wildt
    Ron A. A. Mathôt
    Clinical Pharmacokinetics, 2016, 55 : 1129 - 1143
  • [19] EFFECTS OF CYP3A5 POLYMORPHISM AND INTRA-PATIENT TACROLIMUS VARIABILITY ON KIDNEY ALLOGRAFT SURVIVAL AFTER KIDNEY TRANSPLANTATION
    Sasisakulporn, Jaruwit
    Phakdeekitcharoen, Bunyong
    Kantachuvesiri, Surasak
    Sumethkul, Vasant
    Kitiyakara, Chagriya
    Disthabanchong, Sinee
    Nongnuch, Arkom
    Wiwattanathum, Punlop
    Ingsathit, Atiporn
    TRANSPLANT INTERNATIONAL, 2019, 32 : 62 - 62
  • [20] Tacrolimus Dose Requirement Based on the CYP3A5 Genotype in Renal Transplant Patients
    Qu, L.
    Xie, Z.
    Huang, H.
    Jiang, H.
    Chen, J.
    Jiang, H.
    Jiang, H.
    Chen, J.
    Chen, J.
    Chen, J.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2017, 17 : 747 - 747
12345